Cristina Colon-Semenza

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Cristina Colon-Semenza sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

Cristina Colon-Semenza: 1 sponsored US clinical trial, 1 recruiting.

Cristina Colon-Semenza sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Parkinson Disease (PD), with 1 trials.

Mid-pack sponsor footprint

Cristina Colon-Semenza is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

1 total, page 1 of 1

RECRUITING NA

Daily Amino Acid Supplementation for People With Parkinson's Disease

NCT07115563

Therapeutic Areas

Parkinson Disease (PD) 1

What is open in the Cristina Colon-Semenza pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Parkinson Disease (PD) (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Cristina Colon-Semenza: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Cristina Colon-Semenza sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share Cristina Colon-Semenza1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Cristina Colon-Semenza sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Cristina Colon-Semenza sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Cristina Colon-Semenza page

1 registered trials is a research-attention snapshot, not an endorsement of Cristina Colon-Semenza or any single study.

  • 1 of Cristina Colon-Semenza's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Parkinson Disease (PD) is the condition Cristina Colon-Semenza studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Parkinson Disease (PD) trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Cristina Colon-Semenza pipeline card: 1 registered trials from official public datasets.Report a data error.